Simulations Plus (NASDAQ:SLP) Trading Up 7.8% – Here’s Why

Shares of Simulations Plus, Inc. (NASDAQ:SLP) traded up 7.8% during mid-day trading on Friday . The company traded as high as $32.59 and last traded at $32.38. 191,068 shares changed hands during trading, an increase of 40% from the average session volume of 136,422 shares. The stock had previously closed at $30.04.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on SLP. KeyCorp began coverage on Simulations Plus in a research report on Monday, July 29th. They issued an “overweight” rating and a $47.00 price target on the stock. StockNews.com downgraded Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. BTIG Research reduced their price objective on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, October 24th. Stephens began coverage on shares of Simulations Plus in a research note on Friday, November 15th. They issued an “overweight” rating and a $39.00 price objective on the stock. Finally, William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, November 6th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $51.40.

Simulations Plus Trading Up 4.3 %

The company has a market cap of $628.59 million, a price-to-earnings ratio of 63.92 and a beta of 0.71. The company has a fifty day moving average price of $30.80 and a two-hundred day moving average price of $38.31.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. The firm had revenue of $18.70 million for the quarter, compared to the consensus estimate of $19.73 million. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The business’s revenue was up 19.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.18 earnings per share. Sell-side analysts anticipate that Simulations Plus, Inc. will post 1.12 EPS for the current fiscal year.

Insider Activity at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, November 1st. The stock was sold at an average price of $27.66, for a total transaction of $553,200.00. Following the completion of the transaction, the director now owns 3,462,584 shares in the company, valued at $95,775,073.44. This trade represents a 0.57 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold a total of 60,750 shares of company stock valued at $1,905,655 over the last quarter. 20.90% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in shares of Simulations Plus by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 1,135,105 shares of the technology company’s stock worth $46,710,000 after purchasing an additional 12,636 shares during the last quarter. EntryPoint Capital LLC bought a new stake in Simulations Plus during the first quarter worth about $57,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Simulations Plus by 5.9% during the first quarter. Price T Rowe Associates Inc. MD now owns 10,048 shares of the technology company’s stock worth $414,000 after buying an additional 562 shares in the last quarter. Public Employees Retirement System of Ohio bought a new position in shares of Simulations Plus in the first quarter valued at approximately $1,082,000. Finally, Silvercrest Asset Management Group LLC acquired a new position in shares of Simulations Plus in the 1st quarter worth approximately $4,717,000. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.